NASDAQ:VANI Vivani Medical (VANI) Stock Price, News & Analysis → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free VANI Stock Alerts $1.70 -0.03 (-1.73%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$1.68▼$1.7450-Day Range$1.62▼$4.2252-Week Range$0.84▼$7.80Volume38,924 shsAverage Volume2.21 million shsMarket Capitalization$93.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Vivani Medical alerts: Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> About Vivani Medical Stock (NASDAQ:VANI)Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.Read More VANI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VANI Stock News HeadlinesApril 29, 2024 | americanbankingnews.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Declines By 32.4%March 26, 2024 | sfgate.comVivani Medical: Q4 Earnings SnapshotMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.March 26, 2024 | finance.yahoo.comVivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | finance.yahoo.comVivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | investorplace.comVANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023March 16, 2024 | finance.yahoo.comVANI May 2024 6.000 callMarch 16, 2024 | finance.yahoo.comVANI Aug 2024 6.000 callMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.March 16, 2024 | finance.yahoo.comVANI Apr 2024 1.000 callMarch 9, 2024 | morningstar.comThinking about buying stock in Ocean Biomedical, Rush Street Interactive, Vivani Medical, Abeona Therapeutics, or Honest Company?March 6, 2024 | finance.yahoo.comVivani Medical Appoints Daniel Bradbury to its Board of DirectorsMarch 4, 2024 | msn.comVivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare moversMarch 3, 2024 | finance.yahoo.comVANI Mar 2024 2.500 putMarch 1, 2024 | msn.comVivani Medical announces pricing of $15M registered direct offeringMarch 1, 2024 | marketwatch.comVivani Medical Shares Retreat 20% on Securities Purchase AgreementMarch 1, 2024 | markets.businessinsider.comVivani Medical Prices $15 Mln Direct Offering; Stock Down Over 20% In Pre-marketMarch 1, 2024 | businesswire.comVivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and WarrantsMarch 1, 2024 | finance.yahoo.comIndividual investors invested in Vivani Medical, Inc. (NASDAQ:VANI) up 287% last week, insiders too were rewardedFebruary 29, 2024 | ca.news.yahoo.comDoctors, advocates hail federal diabetes drug plan as potentially 'life-changing'February 29, 2024 | ca.news.yahoo.comIt's not 'all in their head.' Heart disease is misdiagnosed in women. And it's killing us.February 28, 2024 | msn.comVivani Medical surges after animal data on obesity implantsFebruary 28, 2024 | investorplace.comWhy Is Vivani Medical (VANI) Stock Up 300% Today?February 28, 2024 | finance.yahoo.comVivani Medical Shows Preclinical Data on Weight Loss ImplantsFebruary 28, 2024 | marketwatch.comVivani Medical Stock Soars 385% After Citing Positive Preclinical Weight Loss DataFebruary 28, 2024 | msn.comVivani shares skyrocket as implant reduces weight in miceFebruary 28, 2024 | finance.yahoo.comEXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies ShowsSee More Headlines Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today5/08/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:VANI CUSIPN/A CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees44Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-87.15% Return on Assets-50.47% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio4.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.41 per share Price / Book4.15Miscellaneous Outstanding Shares54,978,000Free Float24,399,000Market Cap$93.46 million OptionableOptionable Beta3.26 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Adam Mendelsohn Ph.D. (Age 42)Co-Founder, CEO & Director Comp: $312.01kMs. Brigid Ann Makes (Age 68)Chief Financial Officer Comp: $204.63kMr. Truc Le M.B.A. (Age 71)Chief Operations Officer Comp: $337.2kDr. Lisa E. Porter M.D. (Age 60)Chief Medical Officer Comp: $208.4kMr. Donald Dwyer M.B.A.Chief Business OfficerKey CompetitorsFONARNASDAQ:FONRHyperfineNASDAQ:HYPRMovanoNASDAQ:MOVEelectroCoreNASDAQ:ECORElectromedNYSE:ELMDView All CompetitorsInsiders & InstitutionsTanager Wealth Management LLPSold 348,222 shares on 5/1/2024Ownership: 2.370%Commonwealth Equity Services LLCSold 9,500 shares on 4/30/2024Ownership: 0.638%Gregg WilliamsBought 1,078 shares on 2/15/2024Total: $1,088.78 ($1.01/share)Gregg WilliamsBought 1,119 shares on 2/8/2024Total: $1,130.19 ($1.01/share)Gregg WilliamsBought 100 shares on 1/31/2024Total: $101.00 ($1.01/share)View All Insider TransactionsView All Institutional Transactions VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed in 2024? Vivani Medical's stock was trading at $1.02 at the beginning of the year. Since then, VANI stock has increased by 66.7% and is now trading at $1.70. View the best growth stocks for 2024 here. Are investors shorting Vivani Medical? Vivani Medical saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 589,100 shares, a decrease of 32.4% from the March 31st total of 871,100 shares. Based on an average daily trading volume, of 3,010,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 2.0% of the shares of the stock are sold short. View Vivani Medical's Short Interest. When is Vivani Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our VANI earnings forecast. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) announced its earnings results on Tuesday, March, 26th. The company reported ($0.12) earnings per share for the quarter. Who are Vivani Medical's major shareholders? Vivani Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Tanager Wealth Management LLP (2.37%) and Commonwealth Equity Services LLC (0.64%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:VANI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
